Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: WHY MMP licenses are treated as a NON material event

I would think that Option 3 would essentially mean PTSC & TPL, rather than sue for infringement, would instead undercut one another in pricing to entice infringers to license.

Hence, considering TPL's antics over the last 5 years, and the unappetizing prospect described above, my choice for No. 2 as the best course.

Share
New Message
Please login to post a reply